Evidence map›Paper›PMID 33055158›Full record

ArticleScience advances2020

Transcriptional suppression of ribosomal DNA with phase separation.

Satoru Ide, Ryosuke Imai, Hiroko Ochi, Kazuhiro Maeshima

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mechanisms of ribosomopathy and phase separation-related ribosomopathy.Journal of Zhejiang University. Science. B · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Targeting the ribosome to treat multiple myeloma.Molecular therapy. Oncology · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Satoru IdeGenome Dynamics Laboratory, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan. kmaeshim@nig.ac.jp satide@nig.ac.jp.ORCID 0000-0002-6640-1646
Ryosuke ImaiGenome Dynamics Laboratory, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan.
Hiroko OchiGenome Dynamics Laboratory, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan.
Kazuhiro MaeshimaGenome Dynamics Laboratory, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan. kmaeshim@nig.ac.jp satide@nig.ac.jp.ORCID 0000-0003-3909-0341
National Institute of Genetics · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nucleolus is a nuclear body with multiphase liquid droplets for ribosomal RNA (rRNA) transcription. How rRNA transcription is regulated in the droplets remains unclear. Here, using single-molecule tracking of RNA polymerase I (Pol I) and chromatin-bound upstream binding factor (UBF), we reveal suppression of transcription with phase separation. For transcription, active Pol I formed small clusters/condensates that constrained rDNA chromatin in the nucleolus fibrillar center (FC). Treatment with a transcription inhibitor induced Pol I to dissociate from rDNA chromatin and to move like a liquid within the nucleolar cap that transformed from the FC. Expression of a Pol I mutant associated with a craniofacial disorder inhibited transcription by competing with wild-type Pol I clusters and transforming the FC into the nucleolar cap. The cap droplet excluded an initiation factor, ensuring robust silencing. Our findings suggest a mechanism of rRNA transcription suppression via phase separation of intranucleolar molecules governed by Pol I.

Indexed as

Cell NucleolusRNA Polymerase IChromatinDNA, RibosomalRNA, RibosomalTranscription, GeneticChromatinDNA, RibosomalRNA Polymerase IRNA, Ribosomal

Identifiers

PMID33055158
PMCPMC7556839
OpenAlexW3093358877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.